ChemoMetec A/S(DE:CHY)
€96.75+-0.25 (+3.20%)
DE:CHY
ChemoMetec A/S financials statements
€96.75
At close:+-0.25 (+3.20%)
ChemoMetec A/S (CHY) Ratios
6 Followers
ChemoMetec A/S Ratios
DE:CHY's free cash flow for Q4 2026 was kr102.74M. For the 2026 fiscal year, DE:CHY's free cash flow was decreased by kr-16.98M and operating cash flow was kr119.71M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.09 | 3.70 | 4.97 | 4.13 | 2.57 |
| Quick Ratio | 3.11 | 2.95 | 3.76 | 3.19 | 2.08 |
| Cash Ratio | 2.26 | 2.33 | 3.01 | 2.66 | 1.52 |
| Solvency Ratio | 1.71 | 1.34 | 1.31 | 1.54 | 1.20 |
| Operating Cash Flow Ratio | 1.64 | 1.41 | 1.31 | 1.29 | 1.29 |
| Short-Term Operating Cash Flow Coverage | 137.58 | 141.60 | 96.92 | 152.47 | 172.55 |
| Net Current Asset Value | kr 389.30M | kr 388.47M | kr 378.44M | kr 367.73M | kr 208.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.19 | 1.23 | 1.20 | 1.23 | 1.40 |
| Debt Service Coverage Ratio | 117.08 | 97.86 | 96.62 | 92.28 | 68.76 |
| Interest Coverage Ratio | 640.29 | 396.92 | 976.95 | 210.03 | 132.85 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.29 | 0.40 | 0.25 | 0.47 | 0.48 |
| Net Debt to EBITDA | -1.02 | -1.30 | -1.56 | -1.26 | -0.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 95.10% | 93.93% | 90.13% | 88.97% | 89.70% |
| EBIT Margin | 49.11% | 47.73% | 43.34% | 52.08% | 47.78% |
| EBITDA Margin | 55.03% | 52.07% | 45.75% | 55.22% | 51.01% |
| Operating Profit Margin | 49.11% | 49.98% | 43.83% | 51.42% | 47.04% |
| Pretax Profit Margin | 50.52% | 48.43% | 43.29% | 51.84% | 47.44% |
| Net Profit Margin | 39.49% | 37.61% | 33.41% | 40.20% | 37.23% |
| Continuous Operations Profit Margin | 39.49% | 37.61% | 33.41% | 40.20% | 37.23% |
| Net Income Per EBT | 78.18% | 77.66% | 77.18% | 77.56% | 78.47% |
| EBT Per EBIT | 102.86% | 96.90% | 98.77% | 100.81% | 100.84% |
| Return on Assets (ROA) | 23.44% | 22.51% | 20.14% | 27.15% | 31.81% |
| Return on Equity (ROE) | 27.82% | 27.68% | 24.11% | 33.52% | 44.64% |
| Return on Capital Employed (ROCE) | 34.26% | 36.37% | 30.92% | 42.41% | 55.38% |
| Return on Invested Capital (ROIC) | 26.69% | 28.10% | 23.74% | 32.68% | 43.23% |
| Return on Tangible Assets | 30.92% | 27.62% | 23.41% | 30.89% | 36.75% |
| Earnings Yield | 3.20% | 1.83% | 2.60% | 2.20% | 1.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.15 | 6.22 | 5.90 | 7.44 | 6.50 |
| Payables Turnover | 0.66 | 1.87 | 3.63 | 2.79 | 2.59 |
| Inventory Turnover | 0.20 | 0.27 | 0.34 | 0.44 | 0.66 |
| Fixed Asset Turnover | 4.04 | 4.29 | 4.43 | 5.37 | 5.73 |
| Asset Turnover | 0.59 | 0.60 | 0.60 | 0.68 | 0.85 |
| Working Capital Turnover Ratio | 1.29 | 1.26 | 1.07 | 1.51 | 2.21 |
| Cash Conversion Cycle | 1354.79 | 1190.89 | 1044.30 | 757.20 | 467.67 |
| Days of Sales Outstanding | 70.85 | 58.64 | 61.82 | 49.07 | 56.12 |
| Days of Inventory Outstanding | 1838.09 | 1327.47 | 1082.95 | 838.83 | 552.32 |
| Days of Payables Outstanding | 554.15 | 195.22 | 100.46 | 130.70 | 140.77 |
| Operating Cycle | 1908.94 | 1386.11 | 1144.76 | 887.90 | 608.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 12.09 | 11.92 | 7.41 | 8.86 | 10.16 |
| Free Cash Flow Per Share | 10.46 | 10.20 | 4.91 | 6.51 | 6.95 |
| Dividend Paid and CapEx Coverage Ratio | 1.39 | 2.09 | 0.87 | 3.78 | 1.41 |
| Capital Expenditure Coverage Ratio | 7.43 | 6.95 | 2.96 | 3.78 | 3.16 |
| Operating Cash Flow Coverage Ratio | 45.84 | 32.39 | 31.05 | 21.53 | 26.03 |
| Operating Cash Flow to Sales Ratio | 0.41 | 0.42 | 0.32 | 0.35 | 0.41 |
| Free Cash Flow Yield | 2.89% | 1.75% | 1.63% | 1.40% | 0.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.22 | 54.58 | 38.49 | 45.39 | 82.61 |
| Price-to-Sales (P/S) Ratio | 12.33 | 20.53 | 12.86 | 18.25 | 30.75 |
| Price-to-Book (P/B) Ratio | 8.69 | 15.11 | 9.28 | 15.21 | 36.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 34.62 | 57.28 | 61.37 | 71.56 | 108.92 |
| Price-to-Operating Cash Flow Ratio | 29.96 | 49.03 | 40.66 | 52.61 | 74.49 |
| Price-to-Earnings Growth (PEG) Ratio | 3.76 | 1.48 | -1.62 | 3.75 | 1.03 |
| Enterprise Value Multiple | 21.39 | 38.12 | 26.55 | 31.79 | 59.36 |
| Enterprise Value | 6.02B | 9.84B | 4.95B | 7.80B | 12.97B |
| EV to EBITDA | 21.39 | 38.12 | 26.55 | 31.79 | 59.36 |
| EV to Sales | 11.77 | 19.85 | 12.14 | 17.55 | 30.28 |
| EV to Free Cash Flow | 33.05 | 55.39 | 57.95 | 68.83 | 107.25 |
| EV to Operating Cash Flow | 28.60 | 47.42 | 38.40 | 50.60 | 73.34 |
| Tangible Book Value Per Share | 29.73 | 29.90 | 27.05 | 26.05 | 16.65 |
| Shareholders’ Equity Per Share | 41.69 | 38.69 | 32.48 | 30.63 | 20.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.22 | 0.23 | 0.22 | 0.22 |
| Revenue Per Share | 29.37 | 28.48 | 23.44 | 25.54 | 24.62 |
| Net Income Per Share | 11.60 | 10.71 | 7.83 | 10.27 | 9.16 |
| Tax Burden | 0.78 | 0.78 | 0.77 | 0.78 | 0.78 |
| Interest Burden | 1.03 | 1.01 | 1.00 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.12 | 0.42 | 0.00 | 0.00 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.84 | 1.11 | 0.95 | 0.67 | 0.87 |
Currency in DKK
